RH News : Black Men in Focus in U.S. HIV Drug Trial - by Matthew Bigg

A Smart + Strong Site
Subscribe to:
Real Health magazine
Newsletters
Join Real Health: Facebook Pinterest Twitter YouTube
Back to home » RH News » January 2007
More News:
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
July 2005

emailprint


January 10, 2007

Black Men in Focus in U.S. HIV Drug Trial
(Reuters Health)

by Matthew Bigg

Much of the early AIDS research in the United States focused on gay white men because they were the first group affected and subsequently developed an effective lobbying voice. Now a clinical trial by the AIDS Research Consortium of Atlanta is focusing on gay black men, who are not as well organized but who have a higher incidence of the disease. The trial aims to determine whether an AIDS drug is safe for people who are negative for HIV, the virus that causes AIDS. It has stirred debate among participants and researchers about gay sexuality within the black community and its attitude to safe sex. "The black gay community has become complacent about HIV and STDs (sexually transmitted diseases) as a whole," said Duncan Teague, recruitment coordinator for the project. "A lot of people in the black gay community are looking for love so they have sex because they think that means that that person loves them," Teague said. Blacks make up around 12.8 percent of the U.S. population but comprised 50 percent of new diagnoses of HIV in 2003, according to data from the Centers for Disease Control and Prevention and the U.S. Census Bureau.

In Georgia, 78 percent of people diagnosed with AIDS and 81 percent of people diagnosed with HIV infection in 2005 were black, as were almost all of the women who were newly diagnosed, said Melanie Thompson, the trial's lead investigator.

"African-American men are disproportionately affected by HIV and underrepresented in clinical trials. We are testing in order to know whether a drug is safe for the people who will ultimately use the drug," she said.

"While the study is open to men of any race, we are working hard to enroll as many men of color as possible," she said.

The trial involves giving daily doses of the drug tenofovir, an antiretroviral drug made by Gilead Sciences Inc. and marketed as Viread.

Participants, who could also be given a placebo, complete a computerized questionnaire about their sex lives and get risk-reduction counseling and condoms at every visit.

TUSKEGEE EXPERIMENT

Half the group won't receive the drug for the first nine months to see if taking a pill that might potentially make them less likely to contract HIV might encourage men to take more risks with sexual health.

It's part of a long-term project that includes similar studies in Botswana, Thailand and elsewhere to determine if a drug that suppresses the AIDS virus could one day be used to prevent people from contracting it.

Researchers said one reason for the reluctance of blacks to participate in the study is the legacy of the notorious 40-year-long Tuskegee experiment, which was exposed in 1972 and led to an apology by President Bill Clinton on behalf of the government to the victims.

In that experiment, the U.S. Public Health Service starting in 1932 told 400 blacks with syphilis in Alabama they had "bad blood," leaving the syphilis untreated to study its long-term effects on the body.

Some 43 percent of men enrolled in the AIDS drug study are black, but many others were reluctant to take part because of misunderstandings about what the study entails and fear within the black community about clinical trials, Thompson said.

"My first question was 'Wait, are you going to inject me with the HIV virus?,'" said Dorrington Poitier, who is now taking part.

Atlanta is considered by some the gay capital of black America and gays organize an annual gay black pride festival on the Labor Day weekend.

Despite the large numbers of at-risk men, researchers said lack of organization within the gay black community had made it harder to promote awareness and mobilize against AIDS, which has also killed some community leaders.

"AIDS has sucked so much energy out of the community. The leaders started dropping dead, started getting sick. And we have been trying to replace them but against the odds," Teague said.

Another underlying reason for the prevalence of HIV infection is the stigma still attached to homosexuality within some parts of the black community, which leaves some gay men vulnerable to social isolation that makes poor choices about sex easier.

"People within the black community say: 'It's fine to be gay but...don't wear it on your sleeve. They see black as something you can't really hide but they don't want you to be gay in public," said Anthony McWilliams, a project organizer.



Copyright © 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

FEATURED VIDEO
Check out this really cool video that explains the basics about what happens inside our bodies to cause type 2 diabetes.

REAL HEALTH MAGAZINE

Current Issue
Real Health Archives
Real Health Digital
Real Health Newsletter
Bulk Subscriptions

MOST POPULAR
What you're reading
Is There a Link Between Humor and Depression?
Some Doctors Say Multivitamins Are a Waste of Money
Liquid Found in E-Cigs Can Be Deadly to Children
Which Is Worse on Kids: Having a Parent Divorce, Go to Jail, or Die?
Diabetes Summit Yields Surprising Information About the Disease
Expired Meds: OK to Take, or Major Mistake?

TALK TO US
Tell us what you think
Poll
Have you ever had your eyes checked for glaucoma?
Yes
No

   

Survey
What are your thoughts about vacation?

more surveys

Quiz
The Dating Pool
REAL HEALTH
ON TWITTER
 

[ about Smart + Strong | about Real Health | advertising | contact us | advertising policy ]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.